Tag: Deviation

Case Study: Investigating Sample Preparation Errors in Routine Testing That Pose Regulatory Risks In the highly regulated pharmaceutical sector, even minor errors during sample preparation can lead to significant compliance…

Training Shortcomings in Analysts Lead to Deviation in Routine Testing – A CAPA Investigation In the highly regulated pharmaceutical manufacturing environment, maintaining strict compliance with Good Manufacturing Practices (GMP) is…

Examination of a Sample Preparation Error: Lessons Learned from a Quality Control Deviation In the highly regulated pharmaceutical environment, maintaining data integrity throughout the product lifecycle is paramount. A recent…

Addressing Analyst Training Gaps During Method Transfer: A CAPA Case Study In a recent scenario at a pharmaceutical manufacturing facility, a significant deviation occurred during the analytical method transfer from…

Analysis of Sample Preparation Error Causing Data Integrity Breach in QC Laboratory The integrity of data generated in pharmaceutical laboratories is a foundational element of compliance and regulatory adherence. A…

Analysis of Unapproved Chromatographic Integration during Data Review or Insight into Data Integrity Breaches In the world of pharmaceutical manufacturing, maintaining rigorous data integrity is paramount. A recent incident at…

Understanding Backdated Test Records in Routine Testing: A Case Study In a recent incident at a pharmaceutical manufacturing facility, a critical issue arose surrounding the practice of backdating test records…

Inspection Citation Analysis: Ignoring System Suitability Failures During Stability Studies In a routine internal audit at a mid-sized pharmaceutical manufacturing company, a significant quality control (QC) deviation was identified: a…

A Case Study on Ignoring System Suitability Failures During Method Transfer The pharmaceutical manufacturing sector is no stranger to complexities during the method transfer process. A significant case recently emerged…

Regulatory Risks of Unapproved Chromatographic Integration During Routine Testing In a highly regulated pharmaceutical environment, maintaining data integrity is paramount. A recent incident involving unapproved chromatographic integration during routine testing…

Case Study: Addressing Ignored Repeated OOS Trends during Data Review In the pharmaceutical industry, compliance with Good Manufacturing Practices (GMP) is paramount, especially in the Quality Control (QC) laboratory where…

Analyzing a Data Integrity Breach Due to Analyst Training Gaps During Method Transfers In the pharmaceutical industry, method transfer is a critical process that ensures analytical methods are consistently applied…